Drugs / ADP adoptive cell therapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03391778 | Apr 2018 → Apr 2032 expected | neoplasm | USWM CT, LLC | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ADP adoptive cell therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03391778 ↗ |
| Modality | Cell therapy | “lentiviral vector-based adoptive cell therapy” NCT03391778 ↗ |